Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins

BACKGROUND: HIV/AIDS pandemic is a worldwide public health issue. There is a need for new approaches to develop new antiviral compounds or other therapeutic strategies to limit viral transmission. The envelope glycoproteins gp120 and gp41 of HIV are the main targets for both silver nanoparticles (Ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Lara, Humberto H, Ixtepan-Turrent, Liliana, Garza Treviño, Elsa N, Singh, Dinesh K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180349/
https://www.ncbi.nlm.nih.gov/pubmed/21923937
http://dx.doi.org/10.1186/1477-3155-9-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180349/
https://www.ncbi.nlm.nih.gov/pubmed/21923937
http://dx.doi.org/10.1186/1477-3155-9-38

Ejemplares similares